Why did IDEXX Laboratories change its auditor?

IDEXX Laboratories changed its auditor by terminating its engagement with Arthur Andersen LLP. The filing states this decision was recommended by the Audit Committee and approved by the Board of Directors. Importantly, there were no disagreements on accounting or auditing matters, suggesting the change was not due to contentious issues.

Were there any problems with Arthur Andersen's audits of IDEXX's past financial statements?

No, according to the filing, Arthur Andersen LLP's reports on IDEXX's financial statements for the fiscal years ended December 31, 2001, and 2000, did not contain any adverse opinions, disclaimers of opinion, or qualifications. Furthermore, there were no disagreements on accounting principles, financial statement disclosures, or auditing scope or procedures.

What is the significance of Exhibit 16.1?

Exhibit 16.1 is a letter from Arthur Andersen LLP addressed to the Securities and Exchange Commission. This letter serves to confirm that Arthur Andersen LLP agrees with the statements made by IDEXX Laboratories in the 8-K filing regarding the reasons for the change in certifying accountant and the absence of any disagreements.

What does this auditor change mean for investors?

This auditor change signifies a transition to a new independent auditor for IDEXX Laboratories. While the filing indicates no disputes with the previous auditor, investors should pay attention to the new auditor's reports in future filings. It represents a fresh perspective on the company's financial reporting and internal controls.

IDXX 8-K SEC Disclosure

Summary

IDEXX Laboratories, Inc. (IDXX) filed an 8-K report on March 28, 2002, to announce a significant change in its independent auditor. The company, on March 22, 2002, terminated its engagement with Arthur Andersen LLP, effective immediately. This decision was recommended by the Audit Committee of the Board of Directors and subsequently approved by the full Board. This change in auditors is a crucial development for investors, as it introduces a new perspective on the company's financial reporting and auditing processes. The filing explicitly states that there were no disagreements with Arthur Andersen LLP regarding accounting principles, financial disclosures, or auditing procedures during the past two fiscal years (2000 and 2001) or subsequent interim periods. This suggests the auditor change was not driven by contentious issues, which is a positive signal. Investors should note that a letter from Arthur Andersen LLP confirming these statements has been filed as an exhibit.

Key Highlights

1IDEXX Laboratories terminated its engagement with independent auditor Arthur Andersen LLP on March 22, 2002.
2The decision to change auditors was recommended by the Audit Committee and approved by the Board of Directors.
3There were no disagreements with Arthur Andersen LLP on any accounting, disclosure, or auditing matters in the past two fiscal years or interim periods.
4Arthur Andersen LLP did not issue any adverse, qualified, or disclaimed opinions on IDEXX's financial statements for fiscal years 2000 and 2001.
5The company has filed a letter from Arthur Andersen LLP as Exhibit 16.1 to this Form 8-K, confirming the statements made regarding the auditor change.
6This filing marks a transition to a new auditing firm, which will oversee future financial statement audits.

IDEXX LABORATORIES INC /DE 8-K Report (Mar 29, 2002)

Summary

Key Highlights

Frequently Asked Questions